Traoré’s Controversial Turn: When Revolutionary Pan-Africanism Meets “America First” Aid

Over the past weeks, a wave of health cooperation memorandums between the United States and African states branded under the “America First” Global Health Strategy has spread across the continent. The United States frames these as multi-year partnerships targeting HIV/AIDS, malaria, TB, maternal and child health, and pandemic preparedness. But across Africa, there is rising alarm about the terms attached to these deals, especially data governance, sovereignty, and unequal power dynamics. Zimbabwe publicly rejected a U.S. health funding compact worth around US $367 million, calling the terms “lopsided,” particularly those involving access to health data and biological samples without guarantees of equitable benefits. Zambia similarly objected to U.S. conditions tied to health funding that seemed linked to strategic mineral access and sensitive data, even as negotiations continued. African health officials, including the Africa CDC’s Director‑General, have warned that such bilateral MOUs could transfer control over national health priorities, pathogen surveillance, and data to foreign interests rather than reinforcing regional health autonomy. Meanwhile, some countries, including Nigeria, Uganda, DRC, Kenya, Ethiopia, and others, have signed similar agreements, adding to the sense of a divide across the continent on how to manage foreign health cooperation.

Ibrahim Traoré, the young military leader of Burkina Faso, has been widely celebrated, especially in anti-imperialist and Pan-Africanist discourse, as a revivalist of Sankarist, independence-oriented revolutionary ideals. His rhetoric and domestic policies, including nationalising key resources, repudiating neo-colonial influence, and distancing Burkina Faso from lingering French domination, lit a fire of hope among many who saw him as a beacon of true African sovereignty. So when news emerged that Burkina Faso had signed or was moving forward with a U.S. health cooperation memorandum, particularly one packaged with the “America First” moniker that other African states have publicly rejected, many observers on the continent and within Pan‑Africanist circles reacted with dismay and incredulity.

There are several reasons why Traoré’s acquiescence is viewed as a significant ideological and strategic capitulation. First, sovereignty is more than a rhetorical gesture. Pan-Africanism is rooted in the principle that African nations must exercise sovereign control over their people, data, and resources, not merely declare it in speeches. Allowing foreign powers to house personnel inside the national health system, digitise disease‑reporting infrastructure, and receive real-time health data risks creating a dependency paradigm rather than empowering autonomous capacity. Second, data is the new frontier of neo-colonialism. The backlash to U.S. health MOUs isn’t about rejecting cooperation; it’s about who controls the knowledge that emerges from such cooperation. Health data, pathogen samples, and surveillance information have immense commercial, political, and strategic value. African critics argue that handing this over without reciprocal ownership safeguards is tantamount to ceding future autonomy in public health policy and pharmaceutical access.

Third, there is a pattern of unequal partnership. Zimbabwe’s outright rejection and Zambia’s pushback highlight a continental trend: more African states are waking up to the geopolitical strings attached to aid. Refusing a deal on the grounds of unequal terms has become a brave assertion of continental dignity. Traoré’s choice looks to some like an outlier, a leader veering toward transactional foreign engagement at a time when others are asserting principled limits. Fourth, symbol versus substance matters. In revolutionary ideology, especially the Sankarist tradition that many say Traoré professes, actions should reinforce liberation: breaking dependency, challenging imperial power, and building genuinely self-sufficient institutions. Accepting a health accord with the world’s superpower, framed under a strategy that many African states distrust, raises legitimate questions about whether Burkina Faso is today pursuing strategic autonomy or entering a soft dependency framework.

Finally, strategic fragmentation weakens continental unity. Pan-Africanism thrives on unity in the face of global economic and political imbalances. When some African states embrace bilateral arrangements with external powers under unequal terms while others reject them on sovereignty grounds, it signals a fracture in continental strategic coherence, something that weakens collective bargaining power vis-à-vis global actors.

If Traoré’s leadership was once seen as a rallying point for African self-determination, a young leader unshackling his country from neo-colonial dictates, this embrace of a contentious U.S. health deal is striking precisely because it contradicts the broader trajectory of Pan-African resistance to such dependencies. In the long view, the real test for Traoré and for all self-identifying Pan‑African leaders isn’t found in symbolic rhetoric but in whether their choices today strengthen the collective autonomy of Africa’s peoples, or whether they inadvertently relock their nations into asymmetrical relationships with old global powers. If the promise of solidarity, mutual aid, and liberation means anything in practice, then standing with other African states in rejecting deals that compromise sovereignty and building genuine continental mechanisms for health security is the path toward the African future many of us have fought for.

   Comments0